Curaleaf Holdings Acquires Northern Green Canada
March 19, 2024
Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.
- Buyers
- Curaleaf Holdings, Inc.
- Targets
- Northern Green Canada Inc.
- Industry
- Pharmaceuticals
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Curaleaf Holdings Acquires Minority Stake in Curaleaf International
July 2, 2025
Consumer Products
Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.
-
Curaleaf Acquires EMMAC Life Sciences
March 9, 2021
Healthcare Services
Curaleaf Holdings announced a definitive agreement to acquire EMMAC Life Sciences Limited for approximately US$286 million (85% in Curaleaf shares, 15% cash) plus up to US$57 million of contingent earn-outs. The acquisition gives Curaleaf a developed, vertically integrated platform for entry into the European medical cannabis market, including cultivation, EU‑GMP processing, distribution and R&D across key EU markets.
-
Columbia Care Acquires Green Leaf Medical
December 22, 2020
Healthcare Services
Columbia Care Inc. has signed a definitive agreement to acquire Green Leaf Medical, LLC for approximately $240 million ( $45 million cash and $195 million in Columbia Care common shares). The acquisition expands Columbia Care's cultivation, manufacturing, retail and wholesale footprint across Pennsylvania, Maryland, Ohio and Virginia, and is expected to be immediately accretive to margins and EBITDA pending regulatory approvals.
-
Curaleaf Acquires Bloom Dispensaries
December 28, 2021
Consumer Products
Curaleaf Holdings, Inc. agreed to acquire Bloom Dispensaries, a vertically integrated single-state cannabis operator in Arizona, in an all-cash transaction valued at approximately US$211 million. The deal adds four retail dispensaries (Phoenix, Tucson, Peoria, Sedona) plus ~63,500 sq. ft. of adjacent cultivation and processing space in north Phoenix; Curaleaf will pay $51 million cash at close and the remainder via three promissory notes, and Bloom generated estimated 2021 revenue of ~$66 million with EBITDA margins above 40%.
-
Green Thumb Industries Acquires LeafLine Industries to Enter Minnesota
December 30, 2021
Healthcare Services
Green Thumb Industries Inc. has closed the acquisition of LeafLine Industries, a licensed Minnesota medical cannabis cultivator and dispensary operator. The deal includes a cultivation facility and five operating retail locations (Eagan, Hibbing, St. Cloud, St. Paul and Willmar), adds ~100+ employees to Green Thumb, and represents a strategic entry into the Minnesota medical cannabis market.
-
Aurora Cannabis Acquires Remaining Stake in MedReleaf Australia (Indica Industries)
February 8, 2024
Healthcare Services
Aurora Cannabis, through a wholly owned subsidiary, acquired the remaining ~90% equity interest in Indica Industries Pty Ltd (doing business as MedReleaf Australia) at an enterprise value of AUD$50 million. Consideration included AUD$9.45 million in cash and approximately 69.5 million Aurora common shares; MedReleaf Australia generated roughly AUD$40 million of trailing 12-month net revenue and holds the #2 position in the Australian medical cannabis market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.